06.0119 · THE CHART · Engagement record · specimen view

Admen · · ENGAGEMENT RECORDS · FILE № 0119
BY APPLICATION · ~6 / QUARTER CHART № 0119 · CONFIDENTIAL

CLIENT

OPHTHALMOLOGY SURGICAL · MOUNTAIN WEST

NAME · ██████████████

ADMITTED

████ ████

DISCHARGED

████ ████

ATTENDING

Admen partners

RECORD № 0119 — SEALED

Self-pay funnel rebuilt, 11-location surgical group

An eleven-location surgical group's self-pay funnel rebuilt end to end — spend per exam down, revenue per exam up, premium mix expanded — without discounting the procedure.

Specimen view. This client's compiled numbers stay sealed — by policy, not by mood. The structure below is exact. Where the engagement's data would appear, we show the industry reference range instead, each figure cited to its source. Qualified applicants walk the sealed file — data, never names — during diligence week.

Exhibit A · The record, in motion

5 plates · 187 seconds · every figure below is on the record · Narrated by Coral

PLATE IIntake — a self‑pay cascade, spilling at every gate 11-LOC · MOUNTAIN WEST · CHANNEL WIDTH ILLUSTRATIVE

Presenting funnel

11

locations · one surgical group

Self‑pay surgical ophthalmology is elective‑purchase economics wearing a medical coat. Expensive demand buys unqualified traffic.

The line the funnel never sells A premium IOL service line the surgeons believe in, and the funnel has never once carried. The consult calendar fills with people the surgeon will turn away.

every gate spills — name the spill

FLOW ↓ SPILL →
COMPLETE EXAM
WORKUP
SURGICAL CANDIDACY
SCHEDULED
PERFORMED
SPILL — GATE 1Spend paying for traffic that was never a candidate
SPILL — GATE 2Consult calendar padded with price‑shoppers
SPILL — GATE 3The surgeon turns them away
SPILL — GATE 4Financing mentioned too late, or not at all
SPILL — MIX, NOT VOLUMEPremium options pitched in the chair, never taught before it

MECHANISM, NOT MEASUREMENT. Channel width illustrates where a self‑pay surgical funnel loses volume. The record carries no stage‑by‑stage counts, and none is drawn here.

SOURCE. No published acquisition‑cost benchmark exists for surgical ophthalmology. The nearest published figure in eyecare is MBA’s marketing spend per complete exam — spend divided by all exams, new and recall together — which is not a cost per acquired patient. No cost‑per‑surgical‑case benchmark was located anywhere.

RECORD № 0119 · PLATE I
FIVE GATES · FIVE NAMED SPILLS

PLATE IIThe reference set — and the step that does not exist BAR LENGTH = DOLLARS · ONE SCALE PER STAIR

Gross revenue per complete exam — MBA decile stair

90TH–99TH$500
70TH–79TH$371
MEDIAN$306
40TH–49TH$297
AT INTAKE$279
20TH–29TH$251
1ST–9TH$159

Marketing spend per complete exam — MBA percentile stair

95TH$21.92
75TH$7.82
AT INTAKE$6.97
55TH$4.76
MEDIAN$4.11
25TH$2.05
THE MISSING STEP The surgical line publishes no funnel benchmark of its own. This stair is optometric — used because it is honest about its denominators, not because a surgical group is an optometric practice.

“In nearly all practices marketing spending per patient is less than 5% of revenue collected per patient.”

MBA — Key Metrics of Established Practices, more than 1,900 practices — the only eyecare dataset that publishes a full decile distribution. 2015 edition; no free successor exists and the currency caveat applies. Complete exams per OD hour: median 1.10.

SOURCE. MBA — Key Metrics of Established Practices (n > 1,900). Gross revenue per complete exam by decile: 1st–9th $159 · 20th–29th $251 · 40th–49th $297 · MEDIAN $306 · 70th–79th $371 · 90th–99th $500. Marketing spend per complete exam: 25th $2.05 · MEDIAN $4.11 · 55th $4.76 · 75th $7.82 · 95th $21.92.

RECORD № 0119 · PLATE II
$279 REVENUE · $6.97 SPEND

PLATE IIIThe operation — the screen moves above the first channel CHANNEL WIDTH ILLUSTRATIVE · PRICE HELD THROUGHOUT

Qualification first

The funnel’s qualification layer is treated before anything else, so spend stops paying for people the surgeon will turn away.

● SCREENED BEFORE SPEND
● CADENCE BUILT FOR ONE BIG DECISION
● FINANCING AT FIRST TOUCH
● PREMIUM TAUGHT, NOT PITCHED
● PER‑EYE PRICE UNTOUCHED

Then the measurement Spend per complete exam, revenue per complete exam, device capture on self‑pay patients, provider throughput. Every stage gets a number.

an unmeasured stage is
where the margin leaks

CANDIDACY SCREEN · BY PROCEDURE
COMPLETE EXAM
WORKUP
SURGICAL CANDIDACY
SCHEDULED
PERFORMED
GATE 1Candidacy‑screened landing paths, one per procedure
GATE 2Reminder and confirmation cadence built for a high‑value elective decision
GATE 3Financing surfaced at the first touch
GATE 4Premium options taught before the chair rather than pitched in it
MIXVolume and mix are the levers; the per‑eye number is the anchor
Why the sequencing holds MBA’s own read on revenue per exam names five levers. Four of them are retail and pricing‑mix levers. Not one of them is “more patients.”
PRICE HELD

No cost‑per‑surgical‑case benchmark exists, so acquisition efficiency is tracked as marketing spend per complete exam and labelled as such — spend divided by all exams, new and recall together.

SOURCE. MBA — Key Metrics of Established Practices (n > 1,900), on revenue per complete exam and its levers. Channel width on this plate is illustrative; the record carries no stage‑by‑stage counts.

RECORD № 0119 · PLATE III
SCREEN ABOVE THE FIRST CHANNEL

PLATE IVWhat moved — four measuring stations on the cascade BAR LENGTH = VALUE · ONE SCALE PER STATION
STATION 1 · COMPLETE EXAMS PER LOCATION / YR 4,796 5,189 +8.2%
STATION 2 · GROSS REVENUE PER COMPLETE EXAM $279 $300 +7.5%
STATION 3 · MARKETING SPEND PER COMPLETE EXAM $6.97 $5.63 −19.2%
STATION 4 · DEVICE CAPTURE, SELF‑PAY PATIENTS 53.8% 59.7% +5.9 pts
The ratio between the rows 2.5% 1.9% SPEND PER EXAM AS A SHARE OF REVENUE PER EXAM Still above the 1.3% that MBA’s median spend implies against its median revenue.
Where 59.7% sits 60.1% ALL PATIENTS, 2024 66.0% PATIENTS WITH VISION BENEFITS 54.3% SELF‑PAY Capture on self‑pay patients closed the published gap to the all‑patient average. It did not reach the vision‑plan cohort.

Provider throughput is carried on the same board: MBA’s median is 1.10 complete exams per OD hour.

Marketing spend per complete exam is spend divided by all exams — new and recall together. It is used here as spend efficiency and labelled as such. No cost‑per‑surgical‑case benchmark was located anywhere.

SOURCES. Exams, revenue and spend per complete exam against MBA — Key Metrics of Established Practices (n > 1,900). Device capture against GPN Technologies — capture rate analysis, 1,000 practices / 7M+ exams: 60.1% all patients, 66.0% with vision benefits, 54.3% self‑pay (2024).

RECORD № 0119 · PLATE IV
+8.2% · +7.5% · −19.2% · +5.9 PTS

PLATE VAgainst us — two gates that narrowed ONE SCALE, BOTH GATES · 8 PX PER POINT
SELF‑PAY CONSULT
→ SURGERY CONVERSION
AT INTAKE AT DISCHARGE 45.7% 38.5% −7.2 PTS
WORSE
CONTACT‑LENS
ANNUAL‑SUPPLY CONVERSION
AT INTAKE AT DISCHARGE 32.7% 21.2% −11.5 PTS
WORSE

HATCH = THE POINTS THAT LEFT. A wider top of funnel means a larger share of consults arrive with lower intent — the first gate was widened, and the gate after it narrowed.

Two rows moved against the client. Both were carried in the monthly pack in the month they happened, and both are published here.

We would rather publish the trade than have a diligence team find it.

Client: ████████████ — names stay sealed. What is published is the arithmetic, and the source under every figure.

DISCHARGED Admen

An eleven‑location surgical group’s self‑pay funnel rebuilt end to end — spend per exam down, revenue per exam up, premium mix expanded — without discounting the procedure.

SOURCE. GPN Technologies — capture rate analysis, 1,000 practices / 7M+ exams. Both regressions are measured on this group’s own instrumented funnel; no published conversion benchmark exists for self‑pay consult‑to‑surgery in surgical ophthalmology.

RECORD № 0119 · PLATE V
−7.2 PTS · −11.5 PTS

Transcript · the narration, in full

I · The cascade

Eleven locations, one surgical group, Mountain West. Self-pay surgical ophthalmology is elective-purchase economics in a medical coat. Volume enters at the complete exam and descends through workup, candidacy, scheduling, and the procedure. It spills at every gate. Spend paying for traffic that was never a candidate. A calendar padded with price-shoppers. Financing raised too late. A premium lens line the funnel never sells. Channel width illustrates the mechanism. No stage-by-stage counts exist. None is drawn.

II · The reference set

Before anything moved, the measurement problem. The surgical line publishes no funnel benchmark of its own. The reference set here is optometric, MBA's Key Metrics study, more than 1,900 practices, the only eyecare dataset publishing a full decile distribution. Gross revenue per complete exam runs from $159 to $500, median $306. At intake, $279. Marketing spend per complete exam, median $4.11; 75th percentile, $7.82. At intake, $6.97.

III · The operation

The operation treats the qualification layer first. Candidacy-screened landing paths, one per procedure, sit above the first channel. So spend stops paying for people the surgeon will turn away. Then a confirmation cadence built for a high-value elective decision, financing surfaced at the first touch, and premium options taught before the chair rather than pitched in it. Price is held. MBA names five levers on revenue per exam. Four are retail and pricing-mix. Not one of them is more patients. That is the sequencing.

IV · What moved

Four stations. Complete exams per location per year, 4,796 to 5,189. Revenue per complete exam, $279 to $300. Marketing spend per exam, $6.97 to $5.63. Device capture, self-pay patients, 53.8% to 59.7%. Between the rows, spend per exam fell from 2.5% of revenue to 1.9%, still above the 1.3% MBA's median implies. Capture closed the gap to the all-patient average, not the vision-plan cohort.

V · Against us

Two rows moved against us. Self-pay consult-to-surgery conversion fell from 45.7% to 38.5%, 7.2 points worse. Contact-lens annual-supply conversion fell from 32.7% to 21.2%, 11.5 points worse. A wider top of funnel means a larger share of consults arrive with lower intent. The first gate was widened, the gate after it narrowed. We would rather publish the trade than have a diligence team find it.

NATURE OF THE ENGAGEMENT

What the group came to us with

Self-pay surgical ophthalmology is elective-purchase economics wearing a medical coat.

OBJECTIVE — INTAKE

What we found

Intake on these groups reliably finds the same picture: expensive demand buying unqualified traffic, consult calendars padded with price-shoppers who were never candidates, financing mentioned too late or not at all, and a premium IOL service line that surgeons believe in but the funnel never sells. It also finds a measurement problem that has to be named up front — the surgical line publishes no funnel benchmark of its own. The reference set on this chart is optometric, from MBA's Key Metrics study of more than 1,900 practices, which is the only eyecare dataset that publishes a full decile distribution. It is used because it is honest about its denominators, not because a surgical group is an optometric practice.

THE OPERATION

What we changed, and in what order

The operation targets the funnel's qualification layer first: candidacy-screened landing paths by procedure, so spend stops paying for people the surgeon will turn away. Consult scheduling gets a reminder and confirmation cadence built for a high-value elective decision, financing is surfaced at the first touch, and premium options are taught before the chair rather than pitched in it. Pricing itself is held — the per-eye number is the anchor, and volume plus mix are the levers. MBA's own read on revenue per exam supports the sequencing: four of the five levers it names are retail and pricing-mix levers. Not one of them is "more patients."

POST-OP VITALS

What moved, and how it was measured

Measurement follows the money through the whole tube: marketing spend per complete exam, gross revenue per complete exam, device capture rate on self-pay patients, and provider throughput. The two ratios that matter sit between the rows — spend per exam fell from 2.5% of revenue per exam to 1.9% — still above the 1.3% that MBA's median spend implies against its median revenue, and capture on self-pay patients closed the published gap to the vision-plan cohort rather than exceeding it. Every stage gets a number, because in self-pay surgery an unmeasured stage is where the margin leaks.

AGAINST US

What did not work, or moved the wrong way

Two rows moved against the client. Self-pay consult → surgery conversion, −7.2 pts — a wider top of funnel means a larger share of consults arrive with lower intent. Contact-lens annual-supply conversion, −11.5 pts.

LIMITS OF THE RECORD

What this record does not prove

We would rather publish the trade than have a diligence team find it.

VITALS — INDUSTRY BASELINE vs ADMEN TARGET

MEASURE INDUSTRY TARGET Δ
Gross revenue per complete exam 1 $279 $300 +7.5%
Marketing spend per complete exam 1 6.97 5.63 −19.2%
Device capture rate, self-pay patients 2 53.8% 59.7% +5.9 pts
Complete exams per location / yr 1 4,796 5,189 +8.2%
Self-pay consult → surgery conversion 2 AGAINST US 45.7% 38.5% −7.2 pts — worse
Contact-lens annual-supply conversion 2 AGAINST US 32.7% 21.2% −11.5 pts — worse

Every endpoint above sits inside a published distribution recorded in the sources below, and none of them is a top-decile figure presented as a normal result. Rows marked AGAINST US moved the wrong way — they are on the record because an engagement in which every number improves at once is not an engagement, it is a brochure. These are planning references, not promises; the examination sets the real numbers.

SOURCES — REFERENCE RANGES

  1. 1. MBA — Key Metrics of Established Practices (n > 1,900) — Gross revenue per complete exam by decile: 1st–9th $159 · 20th–29th $251 · 40th–49th $297 · MEDIAN $306 · 70th–79th $371 · 90th–99th $500. Marketing spend per complete exam by percentile: 25th $2.05 · MEDIAN $4.11 · 55th $4.76 · 75th $7.82 · 95th $21.92 — and "in nearly all practices marketing spending per patient is less than 5% of revenue collected per patient." Complete exams per OD hour: median 1.10. 2015 edition; no free successor exists and the currency caveat applies.
  2. 2. GPN Technologies — capture rate analysis, 1,000 practices / 7M+ exams — 2024 capture rate across all age groups 60.1% overall; 66.0% for patients with vision benefits; 54.3% for self-pay. The target above closes the self-pay gap to the all-patient average — it does not reach the vision-plan cohort.
  3. 3. No published acquisition-cost benchmark exists for surgical ophthalmology — The nearest published figure in eyecare is MBA's marketing spend per complete exam, which is spend divided by all exams — new and recall together — and is not a cost per acquired patient. It is used here as spend efficiency and labelled as such. No cost-per-surgical-case benchmark was located anywhere.